D4E1

General Information


DRACP ID  DRACP03826

Peptide Name   D4E1

Sequence  FKLRAKIKVRLRAKIKL

Sequence Length  17

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antiviral; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C98H181N31O18

Absent amino acids  CDEGHMNPQSTWY

Common amino acids  K

Mass  236729

Pl  12.83

Basic residues  8

Acidic residues  0

Hydrophobic residues  9

Net charge  8

Boman Index  -3727

Hydrophobicity  -11.76

Aliphatic Index  143.53

Half Life 
  Mammalian: 1.2 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 11751108

Title  In vitro microbicidal activities of cecropin peptides D2A21 and D4E1 and gel formulations containing 01 to 2% D2A21 against Chlamydia trachomatis

Doi Not available

Year  2002

Literature 2

Pubmed ID 12208971

Title  Inhibitory activity of Synthetic peptide peptide antibiotics on feline immunodeficiency virus infectivity in vitro

Doi Not available

Year  2002

Literature 3

Pubmed ID Not available

Title  Periodic antimicrobial peptides

Doi Not available

Year  2006

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  13331

DRACP is developed by Dr.Zheng's team.